Analyst Ratings for Pieris Pharmaceuticals (PIRS)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2021 | Jefferies | Roger Song | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.88 (13.60) |
623.4% | Details |
| 3/13/2020 | Baird | Madhu Kumar | Upgrade | Outperform (Neutral) |
5.00 (N/A) |
2.23 (13.60) |
509.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
